SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Oct 30, 17:00
874.25
28.25 (+3.34%)
VOLUME 2,006
AVERAGE VOLUME
5-Day 2,295
10-Day 1,994
30-Day 3,516
VOLUME SHOCKER
5-Day 2,295
10-Day 1,994
30-Day 3,516
Prev. Close
846.00
Open Price
847.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 840.10 877.50
52 Wk Low/High 725.85 1285.00
LIVE
NSE
Oct 30, 17:00
875.30
25.20 (+2.96%)
VOLUME 13,657
AVERAGE VOLUME
5-Day 6,751
10-Day 7,475
30-Day 11,142
VOLUME SHOCKER
5-Day 6,751
10-Day 7,475
30-Day 11,142
Prev. Close
850.10
Open Price
844.35
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
875.30 (11)
Today’s Low/High 844.35 879.80
52 Wk Low/High 725.20 1286.00
Action in AstraZeneca Pharma

No recommendations so far.

What's your call on AstraZeneca today?
Read 3 investor views

MARKET CAP (Rs Cr)
2,185.63
*P/E
-
*BOOK VALUE (Rs)
68.64
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
23.00
*EPS (TTM)
-
*P/C
-
*PRICE/BOOK
12.74
DIV YIELD.(%)
-%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
68.02 new
DELIVERY AVERAGES
3-Day 43.21%
5-Day 39.09%
8-Day 45.14%
* Based on standalone numbers
Track AstraZeneca on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 03-Nov-2014 (Quarterly Results)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

28 October 2014

buy

SunPharma Oct Fut

Entry Price (Rs)

813.00

Exit Price (Rs)

821.50

Gain (Rs)

9.00

buy

Cipla Oct Fut

Entry Price (Rs)

634.50

Exit Price (Rs)

641.00

Gain (Rs)

6.00

buy

ApolloHospital Oct Fut

Entry Price (Rs)

1,083.50

Exit Price (Rs)

1,109.00

Gain (Rs)

25.00

sell

JustDial Oct Fut

Entry Price (Rs)

1,433.00

Exit Price (Rs)

1,408.00

Gain (Rs)

25.00

buy

MM Oct Fut

Entry Price (Rs)

1,251.00

Exit Price (Rs)

1,273.00

Gain (Rs)

22.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 836.00 847.00  
High Price 885.00 877.50  
Low Price 833.90 840.10  
Last Price 859.55 874.25 1.71
Volume 23,802 2,006 -91.57
Simple Moving Averages
Days BSE NSE
30 896.04 896.07
50 935.97 935.85
150 1057.52 1057.59
200 1008.20 1008.28

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for AstraZeneca

The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
Pre Opening Session Prices 9:00 - 9:15
BSE - No shares traded
NSE
Oct 30, 09:07
844.35
-5.75 (-0.68%)
High
844.35
Low
842.00
News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Standalone (Jun '14)
(Mar '14)
Net Sales 125.57 114.15
Other Income 1.79 1.42
PBDIT -14.17 0.40
Net Profit -17.60 -2.57

Annual Report

Download in PDF format 2014 |2013 |2012 |2011
Balance Sheet
(Mar '14)
(In Rs Cr)
Total Share Capital 5.00
Net Worth 171.60
Total Debt 0.00
Net Block 94.22
Investments 0.00
Net Current Assets 68.07
Total Assets 171.60
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 829.10 -0.10 877.40 552.50 171,720.20
Lupin 1345.90 -0.68 1442.30 841.10 60,436.51
Dr Reddys Labs 3098.10 1.70 3353.85 2250.00 52,781.04
Cipla 650.55 -0.77 663.00 366.70 52,234.05
Cadila Health 1422.25 3.25 1435.00 692.20 29,120.36
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 13Sep' 13Jun' 13May' 13
Promoter75.0075.0075.0075.00
FII15.9315.8315.3115.25
DII0.030.050.030.07
Others9.049.129.669.68
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Block N1, 12th Floor,,Manyata Embassy Business Park,
City
Bangalore
State
Karnataka
Pin Code
560045
Tel. No.
080-23622020-22 080-67748000
Fax No.
080-23622015
REGISTRARS
Name
Integrated Enterprises (India) Ltd.
Address
No.30, Ramana Residency 4th Cross, Sampige Road Malleswaram
City
Bangalore - 560003
State
Karnataka
Tel. No.
080-23460815
Fax No.
080-23460819
Email:
Internet
MANAGEMENT
Name
Designation
D E Udwadia
Chairman
Sanjay Murdeshwar
Managing Director
Robert Ian Haxton
Whole Time Director
Narayan K Seshadri
Director
Ian Brimicombe
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Kwality Recommended on Jun 25th 2014

Recommended price 45.00  |  Peak from reco 58.00 28.89%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About AstraZeneca

AstraZeneca is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,185.63 crore.The company has reported a standalone sales of Rs 125.57 crore and a Net Loss of Rs -17.60 crore for the quarter ended Jun 2014.

The company management includes D E Udwadia - Chairman, Sanjay Murdeshwar - Managing Director, Robert Ian Haxton - Whole Time Director, Narayan K Seshadri - Director, Ian Brimicombe - Director.

It is listed on the BSE with a BSE Code of 506820 and the NSE with an NSE Code of ASTRAZEN.

Its Registered office is at Block N1, 12th Floor,,Manyata Embassy Business Park, Bangalore,Karnataka - 560045.

Their Registrars are Integrated Enterprises (India) Ltd.

Quick Links for AstraZeneca Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of AstraZeneca